NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What additional medication is recommended for diabetes patients with ASCVD 10-yr risk > 20% besides maximum tolerated statin doses?

Ezetimibe
Metformin
Insulin
ACE inhibitors

The correct answer is: Ezetimibe

For diabetes patients with atherosclerotic cardiovascular disease (ASCVD) and a 10-year risk greater than 20%, in addition to maximum tolerated statin doses, the recommended additional medication is Ezetimibe. Ezetimibe is a cholesterol absorption inhibitor that can further lower LDL cholesterol levels when added to statin therapy. It is particularly beneficial in high-risk patients, such as those with diabetes and ASCVD, to further reduce the risk of cardiovascular events. Metformin is a commonly used medication for diabetes but is not specifically indicated for reducing cardiovascular risk in this population. Insulin is used for glycemic control in diabetes and does not directly target cardiovascular risk reduction. ACE inhibitors are commonly used to manage hypertension and heart failure but are not the first-line treatment for reducing cardiovascular risk in diabetes patients with ASCVD.